← FDA Drug Approvals (Drugs@FDA)

LEVETIRACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2015-08-13

Drug application

FDA Application #

ANDA090876

Application type

Abbreviated New Drug Application (Generic)

Brand name

LEVETIRACETAM

Generic name

LEVETIRACETAM

Active ingredients

LEVETIRACETAM

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

Manufacturer

Fresenius Kabi USA, LLC

First approval

2015-08-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown